Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Medulloblastoma × Celecoxib × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Peutz-Jeghers Syndrome 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Medulloblastoma 1 Locally Advanced Rectal Cancer 1 Ependymoma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Adenomatous Polyposis Coli 1

Interventions

Temozolomide 5 Cyclophosphamide 5 Etoposide 4 Radiotherapy 3 lutetium Lu 177 dotatate 2 Vincristine 2 Radiation 2 Cisplatin 2 sodium thiosulfate 1 pegfilgrastim 1 olaparib 1 ibrutinib 1 fludarabine 1 fenofibric acid 1 etoposide phosphate 1 Topotecan 1 Thalidomide 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Platinum 1 ONC206 1 Methotrexate 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Irinotecan 1 Hearing 1 Filgrastim 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡